Search

Your search keyword '"J. Ballarin"' showing total 56 results

Search Constraints

Start Over You searched for: Author "J. Ballarin" Remove constraint Author: "J. Ballarin"
56 results on '"J. Ballarin"'

Search Results

1. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

2. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

3. The MEST score provides earlier risk prediction in lgA nephropathy

4. PRIMARY AND SECONDARY GLOMERULONEPHRITIDES 2

5. Renal development and cystic diseases

6. Primary and secondary glomerulonephritis I

7. A unique Na+/H+exchanger, analogous to NHE1, in the chicken embryonic fibroblast

8. Renal replacement therapy in ADPKD patients : a 25-year survey based on the Catalan registry

9. [Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure]

10. Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1

11. A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: 'MYCYC'. On behalf of the European vasculitis study group

12. Cutaneous ulcers with type I cryoglobulinemia treated with plasmapheresis

13. Clinical nephrology / Glomerulonephritis

14. Clinical Nephrology: primary and secondary glomerulonephritis

16. Evaluation of allograft perfusion by radionuclide first-pass study in renal failure following renal transplantation

17. [Isolated hematurias: histologic and immunologic study]

19. Integral pharmacological management of CKD-MBD I

20. Renal Transplantation during Pregnancy

21. Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework.

22. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

23. Pregnancy in Pateints With Exstrophy-Epispadias Complex: Are Higher Rates of Complications and Spontaneous Abortion Inevitable?

24. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.

25. Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population.

26. IgA Nephropathy in Elderly Patients.

27. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.

28. Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.

29. Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.

30. Markers of endothelial damage in patients with chronic kidney disease on hemodialysis.

31. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.

32. Unfermented grape juice reduce genomic damage on patients undergoing hemodialysis.

33. Genetic damage in patients moving from hemodialysis to online hemodiafiltration.

34. Genomic damage as a biomarker of chronic kidney disease status.

35. Radiosensitivity in patients suffering from chronic kidney disease.

36. Time in hemodialysis modulates the levels of genetic damage in hemodialysis patients.

37. Clinical Uses of 1,25-dihydroxy-19-nor-vitamin D(2) (Paricalcitol).

38. Genomic damage as an independent predictor marker of mortality in hemodialysis patients.

39. Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation.

40. Genomic instability in chronic renal failure patients.

41. Molecular biology of water and salt regulation in the kidney.

42. Genetic damage in chronic renal failure patients is associated with the glomerular filtration rate index.

43. Oxidative DNA damage in chronic renal failure patients.

44. [Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].

45. Calcimimetics in the chronic kidney disease-mineral and bone disorder.

46. Preservation of renal function in a patient with Fabry nephropathy on enzyme replacement therapy.

47. Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease.

48. Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study.

49. Assessment of the arteries in living kidney donors: correlation of magnetic resonance angiography with intraoperative findings.

50. Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins.

Catalog

Books, media, physical & digital resources